MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12185-024-03867-0

Медицинская библиотека · International journal of hematology · 2024

CD34+ and CD34- MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells.

Fukui-Morimoto Ayano, Serizawa Kentaro, Fujimoto Ko, Hanamoto Aki, Iwata Yoshio, Kakutani Hiroaki, Kumode Takahiro, Hirase Chikara, Morita Yasuyoshi, Tatsumi Yoichi, Hanamoto Hitoshi, Tanaka Hirokazu, Matsumura Itaru

СтатьяПеревод пока не подготовлен

Аннотация

Despite the introduction of new drugs, multiple myeloma (MM) still remains incurable. We previously reported that CD34+ MM cells, which are clonogenic and self-renewing, are therapy-resistant and persist as a major component of minimal residual disease, expanding during relapse. To investigate the effects of immunotherapies such as immune-checkpoint inhibitors, CAR-T therapy, and bispecific antibodies on CD34+ MM cells, we analyzed immune profiles of both MM cells and T cells from MM patients using microarrays and flow cytometry. Ingenuity pathway analysis revealed 14 out of 289 canonical pathways were more active in CD34+ MM cells compared to CD34- cells, many of which were involved in inflammation and immune responses. Notably, PD-1 signaling-related genes were highly expressed in CD34+ MM cells. Among 10 immune-checkpoint molecules, CD34+ cells more frequently expressed CD112, CD137L, CD270, CD275, and GAL9 than CD34- cells in both newly diagnosed and relapsed/resistant patients. In addition, CD4+ and CD8+ T cells more frequently expressed TIGIT and CD137, suggesting that CD112/TIGIT and CD137L/CD137 interactions may suppress T-cell activity against CD34+ MM cells. Furthermore, our finding of higher FcRH5 expression on CD34+ MM cells is encouraging for future research into the efficacy of FcRH5-targeted therapy in MM.

Для цитирования: Fukui-Morimoto Ayano, Serizawa Kentaro, Fujimoto Ko, Hanamoto Aki, Iwata Yoshio, Kakutani Hiroaki, Kumode Takahiro, Hirase Chikara, Morita Yasuyoshi, Tatsumi Yoichi, Hanamoto Hitoshi, Tanaka Hirokazu, Matsumura Itaru. CD34+ and CD34- MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells.. International journal of hematology. 2024. DOI: 10.1007/s12185-024-03867-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.